Rituximab was no better than glucocorticoids alone for inducing remission in patients with eosinophilic granulomatosis with polyangiitis.

A US District Judge blocked a law that stopped Medicaid payments to many Planned Parenthood clinics nationwide.

The addition of medial opening wedge high tibial osteotomy to nonsurgical management reduced loss of articular cartilage.

The UP-AA clinical program includes 2 studies assessing the safety and efficacy of upadacitinib in adults and adolescent patients with severe alopecia areata.

Among patients with PsA, MetS was independently associated with a D2T phenotype, even when accounting for fibromyalgia and disease activity.

The incidence of new-onset IA was higher after Lyme disease diagnosis vs influenza, especially during the first year postinfection.

Structured 2-year lifestyle interventions were associated with significantly better cognitive trajectory in older adults.

Obinutuzumab, a B-cell depleting therapy, is being explored for reducing lupus nephritis risks, such as flare.

The FDA is allowing Sarepta to resume shipments of Elevidys (delandistrogene moxeparvovec) to ambulatory patients with Duchenne muscular dystrophy.

The Mediterranean, AHEI, and DASH dietary patterns were linked to reduced risk of type 2 diabetes across ethnic groups.

Maria J. Monroy-Iglesias, Ph.D., from King’s College London, and colleagues used data from the U.K. biobank (151,543 individuals with at least one serum vitamin D level measurement at baseline, 2006 ...

HealthDay News — Women with multiple sclerosis (MS) are less likely to receive disease-modifying therapies (DMTs) than men, according to a study published online July 30 in Neurology.